RESUMO
BACKGROUND: Countries have agreed on reduction targets for tobacco smoking stipulated in the WHO global monitoring framework, for achievement by 2025. In an analysis of data for tobacco smoking prevalence from nationally representative survey data, we aimed to provide comprehensive estimates of recent trends in tobacco smoking, projections for future tobacco smoking, and country-level estimates of probabilities of achieving tobacco smoking targets. METHODS: We used a Bayesian hierarchical meta-regression modelling approach using data from the WHO Comprehensive Information Systems for Tobacco Control to assess trends from 1990 to 2010 and made projections up to 2025 for current tobacco smoking, daily tobacco smoking, current cigarette smoking, and daily cigarette smoking for 173 countries for men and 178 countries for women. Modelling was implemented in Python with DisMod-MR and PyMC. We estimated trends in country-specific prevalence of tobacco use, projections for future tobacco use, and probabilities for decreased tobacco use, increased tobacco use, and achievement of targets for tobacco control from posterior distributions. FINDINGS: During the most recent decade (2000-10), the prevalence of tobacco smoking in men fell in 125 (72%) countries, and in women fell in 156 (88%) countries. If these trends continue, only 37 (21%) countries are on track to achieve their targets for men and 88 (49%) are on track for women, and there would be an estimated 1·1 billion current tobacco smokers (95% credible interval 700 million to 1·6 billion) in 2025. Rapid increases are predicted in Africa for men and in the eastern Mediterranean for both men and women, suggesting the need for enhanced measures for tobacco control in these regions. INTERPRETATION: Our findings show that striking between-country disparities in tobacco use would persist in 2025, with many countries not on track to achieve tobacco control targets and several low-income and middle-income countries at risk of worsening tobacco epidemics if these trends remain unchanged. Immediate, effective, and sustained action is necessary to attain and maintain desirable trajectories for tobacco control and achieve global convergence towards elimination of tobacco use. FUNDING: Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports and Technology, Japan; Department of Health, Australia; Bloomberg Philanthropies.
Assuntos
Fumar/tendências , Adolescente , Adulto , Idoso , Métodos Epidemiológicos , Feminino , Previsões , Saúde Global , Humanos , Masculino , Pessoa de Meia-Idade , Distribuição por Sexo , Fumar/epidemiologia , Adulto JovemRESUMO
SYNOPSIS: Decision making in physical therapy is increasingly informed by evidence in the form of probabilities. Prior beliefs concerning diagnoses, prognoses, and treatment effects are quantitatively revised by the integration of new information derived from the history, physical examination, and other investigations in a well-recognized application of Bayes' theorem. Clinical prediction rule development studies commonly employ such methodology to produce quantified estimates of the likelihood of patients having certain diagnoses or achieving given outcomes. To date, the physical therapy literature has been limited to the discussion and calculation of the point estimate of such probabilities. The degree of precision associated with the construction of posterior probabilities, which requires consideration of both uncertainty associated with pretest probability and uncertainty associated with test accuracy, remains largely unrecognized and unreported. This paper provides an introduction to the calculation of the uncertainty interval, known as a credible interval, around posterior probability estimates. The method for calculating the credible interval is detailed and illustrated with example data from 2 clinical prediction rule development studies. Two relatively quick and simple methods for approximating the credible interval are also outlined. It is anticipated that knowledge of the credible interval will have practical implications for the incorporation of probabilistic evidence in clinical practice. Consistent with reporting standards for interventional and diagnostic studies, it is equally appropriate that studies reporting posterior probabilities calculate and report the level of precision associated with these point estimates.